Outcome and survival of asymptomatic PML in natalizumab‐treated MS patients-Reference-Cited by-同舟云学术

Outcome and survival of asymptomatic PML in natalizumab‐treated MS patients

Published:2014-10 Issue:10 Volume:1 Page:755-764
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Dong‐Si Tuan¹,Richman Sandra¹,Wattjes Mike P.²,Wenten Made¹,Gheuens Sarah¹,Philip Jeffrey³,Datta Shoibal³,McIninch James³,Bozic Carmen¹,Bloomgren Gary¹,Richert Nancy⁴

Affiliation:

1. Drug Safety and Risk Management Biogen Idec Inc. Cambridge Massachusetts

2. MS Center Amsterdam Department of Radiology Nuclear Medicine & PET Research VU University Medical Center Amsterdam The Netherlands

3. Data Sciences Biogen Idec Inc. Cambridge Massachusetts

4. Neurology Research and Development Biogen Idec Inc. Cambridge Massachusetts

Funder

Biogen Idec

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.114

Reference39 articles.

1. Tysabri (natalizumab)[prescribing information].Cambridge MA:Biogen Idec Inc. 2013.

2. European Medicines Agency.Tysabri (natalizumab) summary of product characteristics. Available at:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000603/WC500044686.pdf(accessed 19 June 2014).

3. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

4. Natalizumab

5. Biogen Idec MedInfo. Available at:https://medinfo.biogenidec.com(accessed 21 January 2014).

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases;Neuroimaging Clinics of North America;2024-08

2. Treatment Monitoring in Multiple Sclerosis — Efficacy and Safety;Neuroimaging Clinics of North America;2024-08

3. Progressive multifocal leukoencephalopathy in the clinical practice of a neurologist. Case report;Consilium Medicum;2024-05-09

4. Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials;The Lancet Neurology;2024-05

5. Progressive multifocal leucoencephalopathy isolated to the brainstem and cerebellum;Practical Neurology;2024-03-20